Reported 3 days ago
Boston Scientific announced its acquisition of Nalu Medical for approximately $533 million, enhancing its chronic pain therapy offerings with Nalu's neurostimulation device. This device employs peripheral nerve stimulation to alleviate pain by using electrical impulses, with notable features like a battery-free implant and smartphone control. Analysts view this acquisition as a strategic fit within Boston's neuromodulation portfolio, emphasizing potential market share gains in pain management solutions.
Source: YAHOO